Brainstorm Cell Therapeutics (BCLI) Insider Trading & Ownership → Elon Musk’s Final Masterpiece: “X-9840” (From Paradigm Press) (Ad) Free BCLI Stock Alerts $0.49 -0.03 (-4.85%) (As of 12:21 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Brainstorm Cell Therapeutics (NASDAQ:BCLI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.45%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$20,355.00Number OfInsiders Selling(Last 12 Months)0 Get BCLI Insider Trade Alerts Want to know when executives and insiders are buying or selling Brainstorm Cell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BCLI Insider Buying and Selling by Quarter Ad Porter & CompanyKiss of death from Joe BidenIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. Brainstorm Cell Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/1/2023Stacy LindborgCEOBuy11,500$1.77$20,355.00 (Data available from 1/1/2013 forward) BCLI Insider Trading Activity - Frequently Asked Questions Who is on Brainstorm Cell Therapeutics's Insider Roster? The list of insiders at Brainstorm Cell Therapeutics includes Stacy Lindborg. Learn more on insiders at BCLI. What percentage of Brainstorm Cell Therapeutics stock is owned by insiders? 5.45% of Brainstorm Cell Therapeutics stock is owned by insiders. Learn more on BCLI's insider holdings. Which Brainstorm Cell Therapeutics insiders have been buying company stock? The following insider purchased BCLI shares in the last 24 months: Stacy Lindborg ($20,355.00). How much insider buying is happening at Brainstorm Cell Therapeutics? Insiders have purchased a total of 11,500 BCLI shares in the last 24 months for a total of $20,355.00 bought. More Insider Trading Tools from MarketBeat Related Companies: CSBR Insider Trading SGMO Insider Trading VIGL Insider Trading LIFE Insider Trading OMGA Insider Trading DBVT Insider Trading BLUE Insider Trading ATHA Insider Trading CGTX Insider Trading DTIL Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month This page (NASDAQ:BCLI) was last updated on 5/31/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaThis unknown company solves the biggest issue with AIManward PressWho are Nvidia’s New Silent Partners?Weiss RatingsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBill Gates is all about this tiny $2 stockTimothy SykesHow Biden has already won 2024Porter & CompanyDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brainstorm Cell Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.